Cruise Demand Is Hot. Viking Will Give Investors a New Way to Play It.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 01 2024
0mins
Source: MarketWatch
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RAMP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RAMP
Wall Street analysts forecast RAMP stock price to rise
6 Analyst Rating
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 37.560
Low
31.00
Averages
40.33
High
53.00
Current: 37.560
Low
31.00
Averages
40.33
High
53.00
About RAMP
LiveRamp Holdings, Inc. is a data collaboration technology company. The Company’s data collaboration network seamlessly unites data across advertisers, platforms, publishers, data providers, and commerce media networks. It offers flexibility to collaborate wherever data lives to support a range of data collaboration use cases. The LiveRamp Data Collaboration Platform enables an organization to unify customer and prospect data (first, second, or third-party) to build a single view of the customer in a way that protects consumer privacy. First-party data is data collected firsthand through a company’s-controlled channels. Second-party data is data that a company shares directly with a business partner. Third-party data is data collected and sold by a company through an online data marketplace to companies with which it does not have a direct relationship. It serves a global customer base from locations in the United States, Europe, and the Asia-Pacific (APAC) region.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Transaction Investigation: Halper Sadeh LLC is investigating the sale of Taylor Morrison Home Corporation to Berkshire Hathaway at $72.50 per share, raising concerns about potential shareholder rights violations and prompting shareholders to consider their legal options.
- Shareholder Rights Protection: The firm is also examining the sale of LiveRamp Holdings, Inc. to Publicis Groupe for $38.50 per share, aiming to ensure shareholders are treated fairly and may seek increased consideration in the transaction.
- Merger Analysis: The merger between Equity Residential and AvalonBay Communities, Inc. will result in Equity Residential shareholders owning approximately 48.8% of the combined entity, with Halper Sadeh LLC potentially advocating for more disclosures and shareholder benefits.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, ensuring no upfront costs for clients, and aims to protect global investors' rights against securities fraud and corporate misconduct.
See More
- Avanos Medical Acquisition Investigation: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in a deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Global Business Travel Group Acquisition: Amex GBT will be acquired by Long Lake Management for $9.50 per share in an all-cash transaction valued at around $6.3 billion, with investigations examining if the board failed to conduct a fair process, potentially impacting shareholder interests.
- Equity Residential Merger Investigation: Equity Residential will merge with AvalonBay Communities, with AvalonBay shareholders receiving 2.793 shares of Equity Residential for each share owned, and investigations are looking into whether the board ensured a fair process, affecting shareholder rights.
- LiveRamp Acquisition Review: LiveRamp is to be acquired by Publicis Groupe for $38.50 per share, totaling an enterprise value of $2.167 billion, with investigations questioning if the board fulfilled fiduciary duties to ensure a fair transaction for shareholders.
See More
- Legal Investigation Launched: Halper Sadeh LLC is investigating LiveRamp Holdings, Inc. (NYSE: RAMP) regarding its sale to Publicis Groupe for $38.50 per share, as there may be violations of shareholder rights that investors need to be aware of.
- Merger Impact Analysis: The merger between NextEra Energy, Inc. (NYSE: NEE) and Dominion Energy, Inc. will result in NextEra shareholders owning approximately 74.5% of the combined entity, prompting shareholders to understand the potential implications for their rights.
- Shareholder Rights Protection: InMed Pharmaceuticals, Inc. (NASDAQ: INM) is merging with Mentari Therapeutics, Inc., which is expected to leave InMed shareholders with only about 1.51% ownership in the combined company, highlighting the need for shareholders to be informed about their legal rights.
- Advocacy for Investor Rights: Halper Sadeh LLC represents investors globally, seeking increased consideration and additional disclosures to support those affected by securities fraud and corporate misconduct, thereby enhancing investor protection efforts.
See More
- Shareholder Compensation Investigation: Monteverde & Associates is investigating the transaction between LiveRamp Holdings, Inc. and Publicis Groupe, where LiveRamp shareholders are expected to receive $38.50 per share in cash, potentially providing significant returns for shareholders.
- Merger Transaction Analysis: In the merger between NextEra Energy, Inc. and Dominion Energy, Inc., NextEra shareholders will own approximately 74.5% of the combined company upon closing, demonstrating strong consolidation capabilities in the energy market.
- Share Exchange Proposal: In the NextEra and Dominion transaction, Dominion shareholders are expected to receive 0.8138 shares of NextEra for each share of Dominion, which may impact the long-term interests of shareholders from both companies.
- Emerging Pharma Merger: The merger between InMed Pharmaceuticals, Inc. and Mentari Therapeutics, Inc. is expected to result in InMed shareholders owning approximately 1.51% of the combined company, reflecting integration trends and market potential in the pharmaceutical sector.
See More
- Legal Investigation Launched: Halper Sadeh LLC is investigating LiveRamp Holdings, Inc. (NYSE:RAMP) regarding its sale to Publicis Groupe at $38.50 per share, which may involve potential violations of shareholder rights, prompting shareholders to consider their legal options.
- Merger Impact Analysis: InMed Pharmaceuticals, Inc. (NASDAQ:INM) is merging with Mentari Therapeutics, Inc., with InMed shareholders expected to own approximately 1.51% of the combined entity, a factor that could significantly affect long-term investment returns for shareholders.
- Shareholder Rights Protection: The transaction between Dominion Energy, Inc. (NYSE:D) and NextEra Energy, Inc. involves an exchange of 0.8138 shares of NextEra for each share of Dominion, and Halper Sadeh LLC may seek to negotiate increased consideration and additional disclosures to safeguard shareholder interests.
- Post-Merger Equity Structure: The merger between NextEra Energy, Inc. (NYSE:NEE) and Dominion Energy, Inc. will result in NextEra shareholders owning approximately 74.5% of the combined company, necessitating shareholder awareness of the potential impacts on their equity value post-merger.
See More
- Legal Investigation Launched: Halper Sadeh LLC is investigating LiveRamp Holdings, Inc. (NYSE: RAMP) regarding its sale to Publicis Groupe at $38.50 per share, potentially infringing on shareholder rights.
- Merger Review: The merger between NextEra Energy, Inc. (NYSE: NEE) and Dominion Energy, Inc. will result in NextEra shareholders owning approximately 74.5% of the combined entity, prompting Halper Sadeh LLC to assess the transaction's compliance.
- Pharmaceutical Sale Inquiry: Centessa Pharmaceuticals plc (NASDAQ: CNTA) is being sold to Eli Lilly for $38.00 in cash per share plus up to $9.00 in contingent value rights, with Halper Sadeh LLC reviewing whether this transaction aligns with shareholder interests.
- Financial Transaction Scrutiny: Green Dot Corporation (NYSE: GDOT) is selling for $8.11 in cash and 0.2215 shares of a new publicly traded bank holding company, leading Halper Sadeh LLC to investigate if the terms restrict superior competing offers.
See More











